Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Opdivo
Opdivo
Nektar, Bristol combo drug shows signs of tumor reduction in bladder cancer patients
Yahoo/Reuters
Sat, 02/16/19 - 03:53 pm
Nektar
Bristol-Myers Squibb
bladder cancer
NKTR-214
Opdivo
Bladder cancer readout sees Nektar shares hit
Fierce Biotech
Tue, 02/12/19 - 11:36 am
Nektar Therapeutics
bladder cancer
NKTR-214
Opdivo
Bristol-Myers Squibb
Asco-GU – Bristol’s renal cancer lead looks to be short-lived
EP Vantage
Mon, 02/11/19 - 08:24 pm
renal cell carcinoma
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
clinical trials
Sutent
Forget Bristol-Myers: Regeneron takes on Merck for the heavyweight title in non-small cell lung cancer
Endpoints
Fri, 02/8/19 - 11:40 am
Regeneron
Merck
Bristol-Myers Squibb
PD-1/L1 therapy
Libtayo
Keytruda
Opdivo
non-small cell lung cancer
BMS talks up Celgene merger to divert Opdivo disappointment
Fierce Pharma
Fri, 01/25/19 - 12:08 am
Bristol-Myers Squibb
Celgene
Opdivo
Yervoy
In Another Lung Cancer Setback, Bristol Yanks FDA App For Drug Combo
Xconomy
Thu, 01/24/19 - 10:57 am
Bristol-Myers Squibb
Opdivo
Yervoy
non-small cell lung cancer
FDA
Opdivo meets OS endpoint in esophageal cancer trial
BioCentury
Wed, 01/9/19 - 07:24 pm
Ono Pharmaceutical
Opdivo
esophageal cancer
Bristol-Myers Squibb
Bristol-Myers Squibb and Vedanta Biosciences to Evaluate Opdivo and VE800 in Patients with Advanced or Metastatic Cancers
CP WIre
Mon, 12/10/18 - 11:35 pm
Bristol-Myers Squibb
Vedanta Biosciences
Opdivo
VE800
micro
Bristol-Myers Squibb and Vedanta Biosciences to Evaluate Opdivo and VE800 in Patients with Advanced or Metastatic Cancers
Mon, 12/10/18 - 11:34 pm
Bristol-Myers Squibb
Vedanta Biosciences
Opdivo
VE800
microbiome
BMS' second small-cell trial flop endangers Opdivo lung cancer approval: analyst
Fierce Pharma
Tue, 11/27/18 - 11:39 pm
Bristol-Myers Squibb
Opdivo
Yervoy
extensive-stage small cell lung cancer
Bristol-Myers Drops After Lung-Cancer Drug Study Fails
TheStreet.com
Tue, 11/27/18 - 12:15 pm
Bristol-Myers Squibb
Opdivo
Yeroy
extensive-stage small cell lung cancer
How Bristol-Myers Squibb Company Fell $18.8 Billion in October
Motley Fool
Sun, 11/11/18 - 09:00 pm
Bristol-Myers Squibb
Opdivo
Bristol-Myers Squibb stock drops 6% after FDA delays approval deadline for cancer drug
Marketwatch
Mon, 10/22/18 - 12:21 pm
Bristol-Myers Squibb
clinical trials
Opdivo
Yervoy
FDA
FDA, EMA delay review of Opdivo/Yervoy for first-line NSCLC
BioCentury
Sat, 10/20/18 - 11:13 pm
Bristol-Myers Squibb
Opdivo
FDA
EMA
Yervoy
non-small cell lung cancer
Real threat to Opdivo’s small-cell chances will come from elsewhere
EP Vantage
Tue, 10/16/18 - 09:42 am
Bristol-Myers Squibb
Opdivo
Small-Cell Lung Cancer
FDA
Tecentriq
Roche
Bristol-Myers Squibb's Opdivo Misses Primary Endpoint in Ph III Study in Small Cell Lung Cancer
CP Wire
Fri, 10/12/18 - 10:17 am
Bristol-Myers Squibb
Opdivo
Small-Cell Lung Cancer
clinical trials
Bristol-Myers Squibb's Opdivo Misses Primary Endpoint in Ph III Study in Small Cell Lung Cancer
Fri, 10/12/18 - 09:23 am
Bristol-Myers Squibb
Opdivo
Small-Cell Lung Cancer
Bristol-Myers to invest in Compugen, collaborate in clinical trials
Yahoo/Reuters
Thu, 10/11/18 - 09:43 am
Bristol-Myers Squibb
CompuGen
clinical trials
solid tumors
COM701
Opdivo
Merck follows Opdivo’s suit, prices Keytruda in China at half its U.S. tag
Fierce Pharma
Wed, 09/19/18 - 11:53 am
drug pricing
China
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
Immunotherapy Drugs Slow Skin Cancer That Has Spread to the Brain
New York Times, NY
Thu, 08/23/18 - 11:19 am
melanoma
Opdivo
clinical trials
Bristol-Myers Squibb
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »